Frost & Sullivan Names Angiotech Pharmaceuticals Cardiology Company of the Year.Business Editors/Health/Medical Writers SAN FRANCISCO--(BUSINESS WIRE)--March 25, 2004 Frost & Sullivan, a global consulting firm Noun 1. consulting firm - a firm of experts providing professional advice to an organization for a fee consulting company business firm, firm, house - the members of a business organization that owns or operates one or more establishments; "he worked for a specializing in emerging high technology and industrial markets, announced today that it has named Angiotech Pharmaceuticals Angiotech TSX: ANP is a Vancouver, British Columbia pharmaceutical company. Its products enhance the performance of medical devices and biomaterials through the use of pharmacotherapeutics. Inc. the "2004 Cardiology Company of the Year." Presented to a company that has demonstrated excellence in all operations, the award recognizes outstanding management, consistent growth, and positive social and economic impact on the community and customers. The award also highlights exceptional customer service and the ability to successfully combine technology and marketing. Angiotech invented and oversaw the initial development of the paclitaxel-eluting coronary stent coronary stent Intracoronary stent Cardiology An expandable tubular device which can be inserted percutaneously, and left within a coronary artery lumen to maintain its patency Pros Clinical and angiographic outcomes are better with intracoronary artery stent system, widely regarded as one of the biggest innovations in coronary care of the past decade. The stent has a success rate of about 97%, allowing millions of patients to avoid open heart surgeries and other invasive coronary procedures. Angiotech in 1997 signed a worldwide licensing agreement with Boston Scientific The Boston Scientific Corporation (NYSE: BSX) (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, Corporation, which earlier this month received FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approval to market the company's drug-eluting stent. Angiotech also has a licensing agreement with Cook Incorporated. "Angiotech's development of the paclitaxel-eluting coronary stent system was a major breakthrough in coronary care," said Amit Bohora, a Frost & Sullivan industry analyst. "The company was among the first to identify the benefits of coating medical devices and biomaterials with drugs and is well positioned to be a leader in this fast growing field. Angiotech has an impressive pipeline, and we expect to be hearing a lot more from Angiotech in the years ahead." Frost & Sullivan presented the award to Dr. William L. Hunter, Angiotech's founder, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , at last night's Global Excellence in Medical Devices Awards Banquet. Held in San Francisco, the Frost & Sullivan banquet honored world-class companies for outstanding performance and achievements in the medical devices industry. An annual event, the banquet recognizes the quality and merit of distinguished individuals and companies. This is the first year an award was given in the field of cardiology. About Angiotech Pharmaceuticals Inc. Founded in 1992, Angiotech Pharmaceuticals Inc. is dedicated to enhancing the performance of medical devices and biomaterials through the innovative use of pharmacotherapeutics. The company is based in Vancouver, Canada. To find out more about Angiotech Pharmaceuticals Inc. (Nasdaq:ANPI ANPI Angiotech Pharmaceuticals Inc. (Vancouver, BC, Canada) ANPI Associazione Nazionale Partigiani d'Italia (Italian: National Association of Partisans) ) (TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension :ANP ANP atrial natriuretic peptide. ANP atrial natriuretic peptide. ANP Atrial natriuretic peptide, see there ), visit its Web site at www.angiotech.com. About Frost & Sullivan Founded in 1961, Frost & Sullivan is recognized as a global leader in growth consulting. Frost & Sullivan Awards are presented to companies that demonstrate excellence in their industry, commending the diligence, commitment, and innovative business strategies required to advance in the global marketplace. Frost & Sullivan rigorously analyzes specific criteria to determine award recipients in a vast variety of market industries and landscapes. For further information, visit www.frost.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion